Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Molecular biology of diazepam binding inhibitor.

Authors: Gray, PW 
Citation: Gray PW Neuropharmacology 1987 Jul;26(7B):863-5.
Pubmed: (View Article at PubMed) PMID:2821429

The techniques of molecular biology have rapidly advanced the field of neuropharmacology in recent years. Some of these advantages are presented briefly, followed by an example of the power of nucleic acid analysis: specifically the characterization of the diazepam binding inhibitor (DBI). The diazepam binding inhibitor is a putative endogenous ligand for a regulatory site on the gamma-aminobutyric acid, type A receptor. The complementary deoxyribonucleic acid (cDNA) encoding this 87-residue peptide has been isolated, sequenced and expressed in heterologous systems. Diazepam binding inhibitor is encoded by a multigene family and is expressed in a tissue-specific manner, although expression is not limited to the brain.

Annotation

Objects referenced in this article

Additional Information

 
CRRD Object Information
CRRD ID: 727724
Created: 2003-10-31
Species: All species
Last Modified: 2004-05-25
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.